Tobii provides eye tracking technology for NovaSight’s groundbreaking pediatric Amblyopia treatment
Long-standing Tobii client NovaSight receives prestigious medical journal verification for CureSight, an eye tracking based treatment for Amblyopia (lazy eye).NovaSight is a medical device company in the field of eye care specializing in comprehensive solutions in diagnostic, therapeutic, and prevention through advanced eye tracking technology. CureSight™, the company’s flagship product, is an eye tracking based device for remote digital treatment of amblyopia (lazy eye). CureSight, which received FDA-clearance in October 2022, has been showcased in a study published in the American Journal